{
    "organizations": [],
    "uuid": "54b493ffa7bac26c000da2c3587829384944c3b6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-prothena-announces-global-neurosci/brief-prothena-announces-global-neuroscience-research-development-collaboration-with-celgene-idUSFWN1R20QL",
    "ord_in_thread": 0,
    "title": "BRIEF-Prothena Announces Global Neuroscience Research & Development Collaboration With Celgene",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 20, 2018 / 8:25 PM / Updated 8 minutes ago BRIEF-Prothena Announces Global Neuroscience Research & Development Collaboration With Celgene Reuters Staff 1 Min Read March 20 (Reuters) - Prothena Corporation Plc: * PROTHENA ANNOUNCES GLOBAL NEUROSCIENCE RESEARCH & DEVELOPMENT COLLABORATION WITH CELGENE FOR NOVEL THERAPIES FOR PATIENTS WITH NEURODEGENERATIVE DISEASES * PROTHENA CORPORATION - PROTHENA TO RECEIVE A $100 MILLION UPFRONT PAYMENT AND A $50 MILLION EQUITY INVESTMENT BY CELGENE * PROTHENA CORPORATION- COLLABORATION INCLUDES POTENTIAL LICENSE PAYMENTS, MILESTONES, PLUS ADDITIONAL ROYALTIES ON SALES FROM LICENSED PROGRAMS FOR CO * PROTHENA CORPORATION PLC - CELGENE WILL SUBSCRIBE TO ABOUT 1.2 MILLION OF PROTHENAâ€™S ORDINARY SHARES AT $42.57 PER SHARE Source text for Eikon: Further company coverage:",
    "published": "2018-03-20T22:23:00.000+02:00",
    "crawled": "2018-03-20T22:35:28.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "global",
        "neuroscience",
        "research",
        "development",
        "collaboration",
        "celgene",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "prothena",
        "corporation",
        "plc",
        "prothena",
        "announces",
        "global",
        "neuroscience",
        "research",
        "development",
        "collaboration",
        "celgene",
        "novel",
        "therapy",
        "patient",
        "neurodegenerative",
        "disease",
        "prothena",
        "corporation",
        "prothena",
        "receive",
        "million",
        "upfront",
        "payment",
        "million",
        "equity",
        "investment",
        "celgene",
        "prothena",
        "collaboration",
        "includes",
        "potential",
        "license",
        "payment",
        "milestone",
        "plus",
        "additional",
        "royalty",
        "sale",
        "licensed",
        "program",
        "co",
        "prothena",
        "corporation",
        "plc",
        "celgene",
        "subscribe",
        "million",
        "prothena",
        "ordinary",
        "share",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}